Current position:Home >Product >
(2-cyclohexylmethylamino-quinazolin-4-yl)-(5-methyl-1H-pyrazol-3-yl)-amine
(2-cyclohexylmethylamino-quinazolin-4-yl)-(5-methyl-1H-pyrazol-3-yl)-amine(438204-35-4)
- Name: (2-cyclohexylmethylamino-quinazolin-4-yl)-(5-methyl-1H-pyrazol-3-yl)-amine
- Synonyms:
- Molecular Formula:
- Molecular Weight:336.44
- CAS Registry Number:438204-35-4
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 392331-05-4/benzyl 3-[N-[3-(6-chloro-2-naphthyl)sulfonyl-propionyl]-N-[1-(pyridin-4-yl)-4-piperidyl]amino]propionate
- 225120-89-8/C21H27N5O2
- 637027-36-2/methyl 1-[4-(4-cyanophenoxy)-3-fluorophenyl]sulfonyl-piperazine-2-(R)-carboxylate TFA salt
- 444001-05-2/2-(3-Aminocarbonylphenoxy)-N-[4-(2-oxopiperazin-1-yl)phenyl]-2-phenylacetamide
- 1205535-23-4/C23H20ClF3O3
- 611220-05-4/N-methyl-4-[(1-methyl-2-{4-[(4-methylpiperazin-1-yl)methyl]phenyl}-1H-benzimidazol-5-yl)oxy]pyridine-2-carboxamide
- 313514-65-7/(Z)-2-[5-(4-Dibutylamino-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-ethanesulfonic acid benzoylamide
- 791097-97-7/C20H28NO6PS
- 651022-50-3/N-(4-methoxy-3-(3R)-tetrahydrofuran-3-yloxyphenyl)-N-(3-pyridylmethyl)-4-(4-(4-fluorophenyl)piperazin-1-yl)sulfonylaniline
- 794591-71-2/6-bromo-N-(4-trifluoromethoxyphenyl)-1-phthalazinamine
- 438204-35-4/(2-cyclohexylmethylamino-quinazolin-4-yl)-(5-methyl-1H-pyrazol-3-yl)-amine
- 1070178-15-2/N-(4'-methylbiphenyl-2-yl)-2-[1-(propylsulfonyl)piperidin-4-yl]-1,3-thiazole-4-carboxamide
- 835642-70-1/4-((2-chloro-4-(((2-(methyloxy)ethyl)amino)carbonyl)phenyl)oxy)-N-(2,6-dimethylphenyl)-2-((3-fluoro-4-((3-(1-piperidinyl)propyl)oxy)phenyl)amino)-5-pyrimidinecarboxamide
- 1149333-31-2/N-({[1-({5-chloro-2-[(2-methylpropyl)oxy]phenyl}methyl)-5-methyl-1H-pirazol-3-yl]amino}carbonyl)-7,8-dihydro-1,6-naphthyridine-2-carboxamide hydrochloride
- 1152086-11-7/C24H24Cl2N6O
- 1160607-26-0/2-(4-Chlorobenzyl)-N-[4-(trifluoromethyl)phenyl][1,3]thiazolo[5,4-d]pyrimidin-7-amine
- 1148121-83-8/6-(2-(dimethylamino)ethylamino)-2-phenyl-N-(2-(pyridin-3-ylcarbamoyl)phenyl)pyrimidine-4-carboxamide
- 1008767-75-6/C25H31ClN4O3
- 1163121-22-9/[(R)-3-(6-chloro-benzooxazol-2-ylamino)-pyrrolidin-1-yl]-(4-fluoro-2-methoxy-phenyl)-methanone
- 1140964-04-0/(S)-2-[4-(((2-(dimethylamino)ethyl)ethylamino)carbonyl)phenoxy]-3,3-diethyl-N-[(R)-1-(4-(trifluoromethyl)phenyl)butyl]-4-oxo-1-azetidinecarboxamide
- 1160832-95-0/C20H21F3N4
- 1160832-86-9/C20H21Cl2N5O
- 1160271-19-1/7-[(2,6-dimethylbenzyl)oxy]-4-[4-(1-hydroxy-1-methylethyl)phenyl]-2-naphthoic acid
- 1160056-14-3/C18H16N4O6S
- 844497-41-2/2-tert-butyloxycarbonylamino-2-(2-{4-[4-(4-methoxyphenyl)butoxy]phenyl}-ethyl)propane-1,3-diol
- 457948-87-7/C20H18BrNO3
- 530144-83-3/4-(cyclopentylmethyl)-2-methoxybenzoic acid
- 688799-17-9/(1R)-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-3-[{6-[4-(2'-(1-trityl-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)butoxy]hexyl}amino]ethanol
- 697304-17-9/methyl (2R,3S)-2-({[4-(4-chlorphenyl)-4-hydroxypiperidin-1-yl]carbonyl}amino)-3-(1H-indol-3-yl)butanoate
- 437996-32-2/8-methyl-2-{3-[4-(4-methoxyphenyl)-3,6-dihydro-1(2H)-pyridinyl]propyl}-4(3H)-quinazolinone